+150.4%
AMGN vs CHTR
-81.1%
+231.5%
-24.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CHTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -3.3% | +3.2% | +0.3% |
| 7D | -5.9% | -7.0% | +1.1% | -5.1% |
| 30D | 0.0% | +20.0% | -20.1% | -2.5% |
| 3M | +1.6% | -12.9% | +14.5% | +3.0% |
| 6M | +32.9% | -11.0% | +43.9% | +33.7% |
| YTD | +36.6% | -38.3% | +74.9% | +42.8% |
| 1Y | +34.0% | -33.9% | +67.9% | +38.5% |
| 3Y | +79.2% | -68.8% | +148.1% | +102.8% |
| All | +150.4% | -81.1% | +231.5% | +195.9% |
Cumulative growth
Daily Returns
Daily percentage return beside CHTR.
Daily Out/Under-Performance
Portfolio return minus CHTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CHTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling